Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma
- 58 Downloads
Clear cell renal cell carcinoma (ccRCC) comprises nearly 90% of all diagnosed RCC subtypes and has the worst prognosis and highest metastatic potential. The strongest prognostic factors for patients with ccRCC include histological subtype and Fuhrman grade, which are incorporated into prognostic models. Since ccRCC is a highly vascularized tumor, there may be differences in enhancement patterns on multidetector CT (MDCT) due to the hemodynamics and microvessel density (MVD) of the lesions. This may provide a noninvasive method to characterize incidentally detected low- and high-grade ccRCCs on MDCT. The purpose of our study was to determine the correlation between MDCT enhancement parameters, ccRCC MVD, and Fuhrman grade to determine its utility and value in assessing tumor vascularity and grade in vivo.
In this retrospective, HIPAA-compliant, institutional review board-approved study with waiver of informed consent, 127 consecutive patients with 89 low-grade (LG), and 43 high-grade (HG) ccRCCs underwent preoperative four-phase MDCT. A 3D volume of interest (VOI) was obtained for every tumor and absolute enhancement and the wash-in/wash-out of enhancement for each phase was assessed. Immunohistochemistry on resected specimens was used to quantify MVD. Linear regression and Pearson correlation were used to investigate the strength of the association between 3D VOI enhancement and MVD. Stepwise logistic regression analysis determined independent predictors of HG ccRCC. Cut-off values and odds Ratio (OR) with 95% CIs were reported. The clinical, radiomic, and pathologic features with the highest performance in the stepwise logistic regression analysis were evaluated using receiver operator characteristics (ROC) and area under the curve (AUC).
Absolute enhancement in the nephrographic phase < 52.1 Hounsfield Units (HU) (HR 0.979, 95% CI 0.964–0.994, p value = 0.006), lesion size > 4.3 cm (HR 1.450, 95% CI 1.211–1.738, p value < 0.001), and an intratumoral MVD < 15% (HR 0.932, 95% CI 0.867–1.002, p value = 0.058) were independent predictors of HG ccRCC with an AUC of 0.818 (95% CI 0.725–0.911). HG ccRCCs had a significant association between 3D VOI enhancement and MVD in each post-contrast phase (r2 = 0.238 to 0.455, p < 0.05).
Absolute enhancement of the entire lesion obtained from a 3D VOI in the nephrographic phase on preoperative MDCT can provide quantitative data that are a significant, independent predictor of a high-grade clear cell RCC and can be used to assess tumor vascularity and grade in vivo.
KeywordsClear cell RCC Microvessel density Tumor grade Multiphasic CT Angiogenesis Radiomics
Funding was provided by Society of Abdominal Radiology Howard S. Stern Research [Grant No. 20163335].
Compliance with ethical standards
Conflict of interest
All authors have no conflict of interest.
All data were acquired with IRB approval, followed HIPAA guidelines, and with a waiver of informed consent.
- 2.SEER. Cancer Stat Facts: Kidney and Renal Pelvis Cancer. Available from: https://seer.cancer.gov/statfacts/html/kidrp.html.
- 11.Gerlinger, Rowan, Horswell S, et al. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing. New England Journal of Medicine 2012; 366(10) 883-92.Google Scholar
- 13.Lubner M, Stabo N, Abel EJ, Munoz del Rio A, Pickhardt P. CT Textural Analysis of Large Primary Renal Cell Carcinomas: Pretreatment Tumor Heterogeneity Correlates With Histologic Findings and Clinical Outcomes. AJR 2016; 207: 96-105.Google Scholar
- 14.Yin Q, Hung SC, Wang L, et al. Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear Cell Renal Cell Carcinoma: Proof of Concept Study. Sci Rep 2017; 7: 43356. https://doi.org/10.1038/srep43356.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Coy H, Young JR, Douek M, et al. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor amgiomyolipoma on multiphasic multidetector computed tomography. Abdom Radiol 2017; 42(7): 1919-1928.CrossRefGoogle Scholar
- 22.Villalobos-Gollas M, Aguilar-Davidov B, Culebro-Garcia C, et al. Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal cell carcinoma: additional information for selecting candidates for surveillance protocols. In Urol Nephrol 2012; 44: 1369-1374.CrossRefGoogle Scholar
- 28.Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003 Apr 1; 97(7):1663-71.CrossRefGoogle Scholar
- 32.Jeswani T, Padhani. Imaging tumor angiogenesis. Cancer Imaging 2005; 5(1): 31-138.Google Scholar
- 35.Qian C, Huang D, Wondergem B, Teh B. Complexity of Tumor Vasculature in Clear Cell Renal Cell Carcinoma 2009; 115(10 Suppl): 2282-9.Google Scholar